InvestorLens

VERA — VERA THERAPEUTICS INC

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying VERA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
42
Institutional Conviction
Net distribution · 0 buying vs 0 selling last quarter
36
Macro Tailwind
No Macro Health score published yet
—
Why? — Evidence & Confidence ▾

No tracked investor changed their VERA position last quarter.

Supporting evidence
  • +4 tracked investors reported holding VERA at their latest filing
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 7/25/2026.

About VERA THERAPEUTICS INC (VERA)

VERA THERAPEUTICS INC (VERA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $88M. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in VERA

50
/100
Mixed Activity
Added / Increased0
Reduced0
Exited0

No recent activity recorded.

Crowded Trade Score™

How many top investors track VERA

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

VERA Ownership Composition

How VERA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
58% of tracked value
Institutions
4
tracked investors
Total Reported
$85.6M
combined 13F value
Sectors2
  • Hedge Funds57.8%
  • Other42.2%
Hedge Funds(1)
57.8%
Other(3)
42.2%

Tracked investors reporting VERA

  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    1.2M
    Value
    $49.4M
    % Portfolio
    0.06%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    542K
    Value
    $21.8M
    % Portfolio
    0.00%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    293.5K
    Value
    $11.8M
    % Portfolio
    0.00%
  • Paul Tudor JonesDec 31, 2025
    Tudor Investment Corp
    Shares
    50.1K
    Value
    $2.5M
    % Portfolio
    0.00%

Recent activity

  • No recent activity.

Frequently asked questions

How many institutional investors hold VERA?
4 tracked institutional investors disclosed a position in VERA (VERA THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of VERA?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in VERA, valued at $88M.
Did institutional ownership of VERA increase or decrease?
Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited VERA.
Where does this VERA ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.